Check out this week's QuadCast as we highlight recent reporting from ESMO on best approach to potentially resectable pancreatic cancer, optimal timing of post-op radiosurgery for resected brain mets, the efficacy of dostarlimab on mismatch repair deficient tumors, and more.
Check out this week's QuadCast as we highlight recent reporting from ESMO on best approach to potentially resectable pancreatic cancer, optimal timing of post-op radiosurgery for resected brain mets, the efficacy of dostarlimab on mismatch repair deficient tumors, and more.